Jeffrey A. Russell

Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: Study of pharmacokinetics and early clinical outcomes

Jeffrey A. Russell, Hai T. Tran, Diana Quinlan et al. · Biology of Blood and Marrow Transplantation · 2002 · 289 citations · Full text

Immunotherapy for Acute Myelogenous Leukaemia

R Powles, D. Crowther, Caroline Bateman et al. · British Journal of Cancer · 1973 · 216 citations · Full text

Hematological Malignancy, Acute Myelogenous Leukaemia, Malignant Blood Disorder +7

Sensory ataxic neuropathy as the presenting feature of a novel mitochondrial disease

Ricardo Fadić, Jeffrey A. Russell, V. Vedanarayanan et al. · Neurology · 1997 · 143 citations

Unrelated Patients, Neurological Disorder, Presenting Feature +18

The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide.

Kajori G. Thusu, Frederick C. Morin, Jeffrey A. Russell et al. · American Journal of Respiratory and Critical Care Medicine · 1995 · 117 citations

Hypertension, Nitric Oxide, Oxidative Stress +20

Individualized exercise program for the treatment of severe fatigue in patients after allogeneic hematopoietic stem-cell transplant: a pilot study

Linda E. Carlson, David J. Smith, Jeffrey A. Russell et al. · Bone Marrow Transplantation · 2006 · 113 citations

Physical Activity, Transplantation, Health Sciences +13